SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRamsdens Hldgs Regulatory News (RFX)

Share Price Information for Ramsdens Hldgs (RFX)

Share Price is delayed by 15 minutes
Get Live Data
442.50    7.50 (1.72%)
Bid:
440.00
Ask:
445.00
Spread: 5.00 (1.136%)
Market Cap: £143.17m
RFX Live PriceLast checked at - London Stock Exchange

Intraday Ramsdens Hldgs Share Chart

Director/PDMR Shareholding

26 Jun 2018 14:34

RNS Number : 6452S
Ramsdens Holdings PLC
26 June 2018
Β 

Β 

Ramsdens Holdings PLC

Β 

Director/PDMR transaction notification

Β 

Ramsdens Holdings PLC ('Ramsdens' or the 'Company') announces that on 25 June 2018 Peter Kenyon, Chief Executive Officer, sold 500,000 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares"). Following the sale Peter Kenyon will hold 1,091,250 Ordinary Shares.

Β 

The below notification is made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

Β 

a)

Name

Β 

Peter Kenyon

2

Reason for the notification

Β 

a)

Position/status

Β 

Chief Executive Officer

b)

Initial notification/ Amendment

Β 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Name

Β 

Ramsdens Holdings PLC

b)

LEI

Β 

2138009OAUOROKMFPK95

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Description of the financial instrument, type of instrument

Β 

Β 

Identification code

Β 

Ordinary shares of Β£0.01 in Ramsdens Holdings PLC

Β 

Β 

Β 

Β 

ISIN: GB00BDR6V192

b)

Nature of the transaction

Β 

Sell

c)

Price(s) and volume(s)

Β 

Β 

Price(s)

Volume(s)

Β 

180p

Β 

Β 

500,000

Β 

Β 

Β 

d)

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

N/A

e)

Date of the transaction

Β 

25 June 2018

f)

Place of the transaction

Β 

London Stock Exchange, AIM

Β 

For further information please contact:

Enquiries:

Β 

Ramsdens Holdings PLC Tel: +44 (0) 1642 579957

Peter Kenyon, CEO

Martin Clyburn, CFO

Β 

Liberum Capital Limited, Nominated Adviser Tel: +44 (0) 20 3100 2000

Richard Crawley

Joshua Hughes

Β 

Hudson Sandler (Financial PR) Tel: +44 (0) 20 7796 4133

Alex Brennan

Lucy Wollam

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHSEDFDMFASEDM
Date   Source Headline
3rd Jun 20267:00 amRNSInterim Results - six months ended 31 March 2026
6th May 20267:00 amRNSTrading Update
7th Apr 20262:54 pmRNSDirector/PDMR Shareholding
7th Apr 202611:54 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTrading Update
9th Mar 20263:38 pmRNSResult of AGM
9th Mar 20263:38 pmRNSResult of AGM
12th Feb 20261:45 pmRNSHolding(s) in Company
10th Feb 20267:00 amRNSTrading Update
23rd Jan 20267:00 amRNSNotice of AGM
14th Jan 20267:00 amRNSAnnual Results - year ended 30 September 2025
7th Jan 20267:00 amRNS-RNotice of Annual Results Investor Presentation
12th Dec 20257:00 amRNSAppointment of Nominated Adviser and Broker
24th Nov 20257:00 amRNSDirector/PDMR Shareholding
17th Nov 202510:08 amRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNS-RNotice of Investor Presentation
8th Oct 20257:00 amRNSPre-Close Trading Update
10th Sep 20252:17 pmRNSHolding(s) in Company
21st Aug 20259:35 amRNSHolding(s) in Company
19th Jun 202510:47 amRNSHolding(s) in Company
18th Jun 20257:00 amRNSDirector/PDMR Shareholding
4th Jun 20257:00 amRNSInterim Results - six months ended 31 March 2025
16th May 20257:00 amRNSNotice of Interim Results & Investor Presentation
2nd May 20257:00 amRNSDirector/PDMR Shareholding
28th Apr 20252:54 pmRNSHolding(s) in Company
24th Apr 20259:47 amRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSTrading Update
17th Mar 20254:05 pmRNSChange of Registered Office Address
14th Mar 20253:21 pmRNSDirector/PDMR Shareholding
13th Mar 202510:58 amRNSCSOP update
3rd Mar 20254:27 pmRNSResult of AGM
3rd Mar 20257:00 amRNSAGM Business Update
29th Jan 20257:00 amRNSIssue of Equity, PDMR and Total Voting Rights
23rd Jan 202512:46 pmRNSNotice of AGM
14th Jan 20257:00 amRNSAnnual Results - year ended 30 September 2024
28th Oct 20243:55 pmRNSHolding(s) in Company
11th Oct 20244:31 pmRNSHolding(s) in Company
10th Oct 20247:00 amRNSPre-Close Trading Update and Notice of Results
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSAppointment of Non-Executive Director
8th Aug 20247:00 amRNSDirector/PDMR Shareholding
6th Aug 20247:00 amRNSTrading Update
1st Jul 20247:00 amRNSNominated Adviser and Broker
5th Jun 202411:42 amRNSHolding(s) in Company
5th Jun 20247:00 amRNSInterim Results - six months ended 31 March 2024
24th May 202410:51 amRNSHolding(s) in Company
24th May 20247:00 amRNSNotice of Interim Results Investor Presentation
23rd May 20247:00 amRNSForthcoming Board Changes
16th May 20247:00 amRNSNotice of Interim Results
14th May 202412:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.